In VitroCombination of Anti-Cytomegalovirus Compounds Acting through Different Targets: Role of the Slope Parameter and Insights into Mechanisms of Action
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In VitroCombination of Anti-Cytomegalovirus Compounds Acting through Different Targets: Role of the Slope Parameter and Insights into Mechanisms of Action
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 2, Pages 986-994
Publisher
American Society for Microbiology
Online
2013-11-26
DOI
10.1128/aac.01972-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial
- (2012) D. J. Winston et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Artemisinin-Derived Dimer Diphenyl Phosphate Is an Irreversible Inhibitor of Human Cytomegalovirus Replication
- (2012) Ran He et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human Cytomegalovirus Inhibition by Cardiac Glycosides: Evidence for Involvement of the hERG Gene
- (2012) Arun Kapoor et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A quantitative basis for antiretroviral therapy for HIV-1 infection
- (2012) Benjamin L Jilek et al. NATURE MEDICINE
- First Report of Successful Treatment of Multidrug-Resistant Cytomegalovirus Disease with the Novel Anti-CMV Compound AIC246
- (2011) D. R. Kaul et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cyclopropavir Inhibits the Normal Function of the Human Cytomegalovirus UL97 Kinase
- (2011) Scott H. James et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Artemisinin-Derived Dimer Has Highly Potent Anti-Cytomegalovirus (CMV) and Anti-Cancer Activities
- (2011) Ran He et al. PLoS One
- Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance
- (2011) M. E. S. Sampah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
- (2011) Ran He et al. Virology Journal
- In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246
- (2010) P. Lischka et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral Drug Resistance of Human Cytomegalovirus
- (2010) N. S. Lurain et al. CLINICAL MICROBIOLOGY REVIEWS
- Artemisinin-Derived Dimers Have Greatly Improved Anti-Cytomegalovirus Activity Compared to Artemisinin Monomers
- (2010) Ravit Arav-Boger et al. PLoS One
- The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunates Activity in Cancer Cells
- (2009) V. Konkimalla et al. CURRENT CANCER DRUG TARGETS
- Congenital cytomegalovirus: Public health action towards awareness, prevention, and treatment
- (2009) Gail J. Demmler-Harrison JOURNAL OF CLINICAL VIROLOGY
- Mortality Associated with Resistant Cytomegalovirus among Patients with Cytomegalovirus Retinitis and AIDS
- (2009) Douglas A. Jabs et al. OPHTHALMOLOGY
- The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases Society of America
- (2008) Allan R. Tunkel et al. CLINICAL INFECTIOUS DISEASES
- The Antiviral Activities of Artemisinin and Artesunate
- (2008) Thomas Efferth et al. CLINICAL INFECTIOUS DISEASES
- Platelet-derived growth factor-α receptor activation is required for human cytomegalovirus infection
- (2008) Liliana Soroceanu et al. NATURE
- Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
- (2008) Lin Shen et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started